Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug ApplicationGlobeNewsWire • 06/27/22
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 06/26/22
ROSEN, Top Ranked Investor Counsel, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 06/25/22
SPRO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 25, 2022 in the Class Action Filed on Behalf of Spero Therapeutics, Inc. Limited ShareholdersNewsfile Corp • 06/21/22
SPRO INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPROPRNewsWire • 06/20/22
ROSEN, A LEADING LAW FIRM, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 06/16/22
Spero Therapeutics, Inc. Investor News: Robbins LLP is Investigating Spero Therapeutics, Inc. (SPRO) on Behalf of ShareholdersBusiness Wire • 06/16/22
ROSEN, Top Ranked Investor Counsel, Encourages Spero Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 06/14/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPROPRNewsWire • 06/11/22
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)Business Wire • 06/09/22
Spero Therapeutics, Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Spero Therapeutics, IncPRNewsWire • 06/09/22
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)Business Wire • 06/08/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Spero Therapeutics, Inc. (SPRO) InvestorsBusiness Wire • 06/07/22
ROSEN, Leading Investor Counsel, Encourages Spero Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 06/06/22
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Spero Therapeutics, Inc. (SPRO) InvestorsBusiness Wire • 06/06/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Spero Therapeutics, Inc. (SPRO) InvestorsBusiness Wire • 06/06/22
ROSEN, National Trial Lawyers, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRONewsfile Corp • 06/04/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of InvestorsBusiness Wire • 06/03/22
Bronstein, Gewirtz & Grossman, LLC Notifies Spero Therapeutics, Inc. (SPRO) Shareholders of Class Action and Encourages Investors to Contact the FirmBusiness Wire • 06/03/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of InvestorsBusiness Wire • 06/03/22
SPRO INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPROPRNewsWire • 06/02/22
The Law Offices of Frank R. Cruz Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of InvestorsBusiness Wire • 06/02/22
SPERO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Spero Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 06/02/22
Bronstein, Gewirtz & Grossman, LLC Notifies Spero Therapeutics, Inc. (SPRO) Shareholders of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 06/01/22
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Spero Therapeutics, Inc. (SPRO)Business Wire • 05/31/22